Whole Body Vibration for Peripheral Neuropathy

OHSU Knight Cancer Institute, Portland, OR
Peripheral Neuropathy+2 More ConditionsWhole Body Vibration - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial looks at whether whole body vibration can help improve the health of people with chemotherapy-induced peripheral neuropathy.

Eligible Conditions
  • Chemotherapy-induced Peripheral Neuropathy
  • Cancer
  • Blood Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

4 Primary · 16 Secondary · Reporting Duration: Before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks

0, 12 weeks
Body mass index
Fat mass
Functional balance-sway amount
Functional balance-sway area
Functional balance-sway velocity
Functional mobility
Lean body mass
Objective physical function
Perceived physical function
Symptoms of chemotherapy-induced peripheral neuropathy
1, 12 weeks
Exercise readiness
Week 12
Fatigue Visual Analog Scale
Pain Visual Analog Scale
Up to 12-weeks
Weekly up to 12-weeks
Adverse events

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Usual Care (UC)
1 of 2
Whole body vibration (WBV)
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Whole Body Vibration · No Placebo Group · N/A

Whole body vibration (WBV)
Experimental Group · 1 Intervention: Whole Body Vibration · Intervention Types: Behavioral
Usual Care (UC)NoIntervention Group · 1 Intervention: Usual Care (UC) · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug
Whole Body Vibration
Completed Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks

Who is running the clinical trial?

Oregon Health and Science UniversityOTHER
913 Previous Clinical Trials
6,830,419 Total Patients Enrolled
1 Trials studying Peripheral Neuropathy
1 Patients Enrolled for Peripheral Neuropathy
OHSU Knight Cancer InstituteLead Sponsor
214 Previous Clinical Trials
2,089,686 Total Patients Enrolled
Kerri Winters-Stone, PhDPrincipal InvestigatorOHSU Knight Cancer Institute
3 Previous Clinical Trials
419 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the primary goal of this clinical investigation?

"This medical study, which will be monitored up to 3 months, aims to determine the accrual rate. Secondary objectives include an evaluation of [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) levels with a Brief Pain Inventory (BPI), lean body mass by dual X-ray absorptiometry scans, and fat mass also via DXA scanning." - Anonymous Online Contributor

Unverified Answer

How many individuals have registered for this experiment?

"Affirmative. Information available on clinicaltrials.gov shows that this medical investigation, posted August 5th 2019, is still seeking participants to enrol in the trial at one location with a quota of 40 patients." - Anonymous Online Contributor

Unverified Answer

Is there availability to join this clinical trial?

"Yes, up-to-date information on clinicaltrials.gov indicates that this experiment is now recruiting participants; it was originally posted online on the 5th of August 2019 and edited most recently on 26th August 2022. The researchers need 40 individuals to take part in the trial at one location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.